WEST LAFAYETTE, Ind., June 1, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, announced today that Ron Ellis, President and CEO of Endocyte, will present at the upcoming Jefferies 2011 Global Healthcare Conference on Wednesday, June 8, 2011 at 1:30 p.m. EDT. The conference is being held in New York City.
